Annual revenue:
$3.24B-$3.60B(-52.69%)Summary
- As of today (August 23, 2025), MRNA annual revenue is $3.24 billion, with the most recent change of -$3.60 billion (-52.69%) on December 31, 2024.
- During the last 3 years, MRNA annual revenue has fallen by -$15.18 billion (-82.43%).
- MRNA annual revenue is now -83.07% below its all-time high of $19.11 billion, reached on December 31, 2022.
Performance
MRNA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$142.00M+$34.00M(+31.48%)Summary
- As of today (August 23, 2025), MRNA quarterly revenue is $142.00 million, with the most recent change of +$34.00 million (+31.48%) on June 30, 2025.
- Over the past year, MRNA quarterly revenue has dropped by -$99.00 million (-41.08%).
- MRNA quarterly revenue is now -98.01% below its all-time high of $7.14 billion, reached on December 31, 2021.
Performance
MRNA Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$3.08B-$99.00M(-3.12%)Summary
- As of today (August 23, 2025), MRNA TTM revenue is $3.08 billion, with the most recent change of -$99.00 million (-3.12%) on June 30, 2025.
- Over the past year, MRNA TTM revenue has dropped by -$1.96 billion (-38.95%).
- MRNA TTM revenue is now -86.55% below its all-time high of $22.88 billion, reached on June 30, 2022.
Performance
MRNA TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
MRNA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.7% | -41.1% | -39.0% |
| 3 y3 years | -82.4% | -97.0% | -86.5% |
| 5 y5 years | +5274.6% | +114.0% | +2808.1% |
MRNA Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -83.1% | at low | -97.2% | +31.5% | -86.5% | at low |
| 5 y | 5-year | -83.1% | +5274.6% | -98.0% | +114.0% | -86.5% | +2808.1% |
| alltime | all time | -83.1% | >+9999.0% | -98.0% | >+9999.0% | -86.5% | >+9999.0% |
MRNA Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $142.00M(+31.5%) | $3.08B(-3.1%) |
| Mar 2025 | - | $108.00M(-88.8%) | $3.18B(-1.8%) |
| Dec 2024 | $3.24B(-52.7%) | $966.00M(-48.1%) | $3.24B(-36.2%) |
| Sep 2024 | - | $1.86B(+672.6%) | $5.07B(+0.6%) |
| Jun 2024 | - | $241.00M(+44.3%) | $5.04B(-2.0%) |
| Mar 2024 | - | $167.00M(-94.0%) | $5.14B(-24.9%) |
| Dec 2023 | $6.84B(-64.2%) | $2.80B(+53.1%) | $6.85B(-24.5%) |
| Sep 2023 | - | $1.83B(+432.3%) | $9.07B(-14.1%) |
| Jun 2023 | - | $344.00M(-81.6%) | $10.55B(-29.3%) |
| Mar 2023 | - | $1.87B(-62.8%) | $14.93B(-21.9%) |
| Dec 2022 | $19.11B(+3.8%) | $5.02B(+51.6%) | $19.11B(-10.0%) |
| Sep 2022 | - | $3.31B(-29.8%) | $21.23B(-7.2%) |
| Jun 2022 | - | $4.72B(-22.0%) | $22.88B(+1.6%) |
| Mar 2022 | - | $6.05B(-15.3%) | $22.52B(+22.4%) |
| Dec 2021 | $18.41B(+2191.9%) | $7.14B(+43.7%) | $18.40B(+55.5%) |
| Sep 2021 | - | $4.97B(+14.1%) | $11.83B(+68.5%) |
| Jun 2021 | - | $4.35B(+124.8%) | $7.02B(+156.9%) |
| Mar 2021 | - | $1.94B(+239.4%) | $2.73B(+240.1%) |
| Dec 2020 | $803.39M(+1234.3%) | $570.75M(+261.4%) | $803.39M(+225.7%) |
| Sep 2020 | - | $157.91M(+138.0%) | $246.71M(+133.1%) |
| Jun 2020 | - | $66.35M(+690.9%) | $105.84M(+101.3%) |
| Mar 2020 | - | $8.39M(-40.3%) | $52.57M(-12.7%) |
| Dec 2019 | $60.21M(-55.4%) | $14.05M(-17.5%) | $60.21M(-26.2%) |
| Sep 2019 | - | $17.05M(+30.3%) | $81.58M(-23.2%) |
| Jun 2019 | - | $13.08M(-18.4%) | $106.29M(-12.9%) |
| Mar 2019 | - | $16.02M(-54.8%) | $122.05M(-9.6%) |
| Dec 2018 | $135.07M(-34.4%) | $35.42M(-15.2%) | $135.07M(-29.5%) |
| Sep 2018 | - | $41.76M(+44.7%) | $191.55M(-0.4%) |
| Jun 2018 | - | $28.85M(-0.6%) | $192.27M(+17.7%) |
| Mar 2018 | - | $29.04M(-68.4%) | $163.42M(+21.6%) |
| Dec 2017 | $205.82M(+89.9%) | $91.90M(+116.4%) | $134.38M(+216.4%) |
| Sep 2017 | - | $42.47M(>+9900.0%) | $42.47M(+6146.0%) |
| Dec 2016 | $108.40M(>+9900.0%) | - | - |
| Dec 2015 | $680.00K(+36.0%) | $200.00K(+150.0%) | $680.00K(-30.6%) |
| Sep 2015 | - | $80.00K(-80.0%) | $980.00K(+8.9%) |
| Jun 2015 | - | $400.00K(-20.0%) | $900.00K(+80.0%) |
| Dec 2014 | $500.00K(-76.4%) | $500.00K(-50.0%) | $500.00K(-76.4%) |
| Dec 2013 | $2.12M(-49.8%) | $1.00M(+25.0%) | $2.12M(-13.2%) |
| Sep 2013 | - | $800.00K(+154.0%) | $2.44M(-11.2%) |
| Jun 2013 | - | $315.00K(-76.2%) | $2.74M(-35.0%) |
| Dec 2012 | $4.22M(+88.6%) | $1.32M(+19.5%) | $4.22M(-6.3%) |
| Sep 2012 | - | $1.11M(-33.3%) | $4.50M(+22.3%) |
| Jun 2012 | - | $1.66M(+1165.6%) | $3.68M(+71.0%) |
| Mar 2012 | - | $131.00K(-91.8%) | $2.15M(-3.7%) |
| Dec 2011 | $2.24M(-9.1%) | $1.61M(+461.9%) | $2.24M(+41.3%) |
| Sep 2011 | - | $286.00K(+121.7%) | $1.58M(-34.8%) |
| Jun 2011 | - | $129.00K(-39.7%) | $2.43M(-2.6%) |
| Mar 2011 | - | $214.00K(-77.5%) | $2.49M(+1.2%) |
| Dec 2010 | $2.46M(-83.3%) | $953.00K(-15.7%) | $2.46M(+43.4%) |
| Sep 2010 | - | $1.13M(+485.5%) | $1.72M(+164.3%) |
| Jun 2010 | - | $193.00K(+4.9%) | $649.00K(-15.2%) |
| Mar 2010 | - | $184.00K(-11.5%) | $765.00K(-94.8%) |
| Dec 2009 | $14.73M(+464.7%) | $208.00K(+225.0%) | $14.73M(+0.1%) |
| Sep 2009 | - | $64.00K(-79.3%) | $14.71M(-2.3%) |
| Jun 2009 | - | $309.00K(-97.8%) | $15.05M(-2.9%) |
| Mar 2009 | - | $14.15M(+7467.4%) | $15.50M(+494.0%) |
| Dec 2008 | $2.61M | $187.00K(-53.8%) | $2.61M(-70.4%) |
| Sep 2008 | - | $405.00K(-46.3%) | $8.81M(-14.5%) |
| Jun 2008 | - | $754.00K(-40.3%) | $10.30M(-28.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $1.26M(-80.2%) | $14.41M(-20.6%) |
| Dec 2007 | $18.14M(-36.3%) | $6.39M(+236.7%) | $18.14M(+9.5%) |
| Sep 2007 | - | $1.90M(-61.0%) | $16.57M(-18.0%) |
| Jun 2007 | - | $4.86M(-2.6%) | $20.21M(-24.5%) |
| Mar 2007 | - | $4.99M(+3.7%) | $26.76M(-6.1%) |
| Dec 2006 | $28.49M(+282.5%) | $4.82M(-13.1%) | $28.49M(+14.1%) |
| Sep 2006 | - | $5.54M(-51.4%) | $24.97M(+20.9%) |
| Jun 2006 | - | $11.41M(+69.9%) | $20.65M(+90.5%) |
| Mar 2006 | - | $6.72M(+419.2%) | $10.84M(+45.5%) |
| Dec 2005 | $7.45M(+303.3%) | $1.29M(+5.8%) | $7.45M(-2.1%) |
| Sep 2005 | - | $1.22M(-23.7%) | $7.61M(+15.5%) |
| Jun 2005 | - | $1.60M(-51.9%) | $6.59M(+31.0%) |
| Mar 2005 | - | $3.33M(+129.5%) | $5.03M(+172.3%) |
| Dec 2004 | $1.85M(-90.5%) | $1.45M(+614.8%) | $1.85M(+41.3%) |
| Sep 2004 | - | $203.00K(+351.1%) | $1.31M(-18.2%) |
| Jun 2004 | - | $45.00K(-69.6%) | $1.60M(-90.7%) |
| Mar 2004 | - | $148.00K(-83.8%) | $17.27M(-11.2%) |
| Dec 2003 | $19.44M(+117.9%) | $911.00K(+84.4%) | $19.44M(-4.2%) |
| Sep 2003 | - | $494.00K(-96.9%) | $20.29M(-6.8%) |
| Jun 2003 | - | $15.72M(+578.4%) | $21.78M(+124.2%) |
| Mar 2003 | - | $2.32M(+31.9%) | $9.71M(+8.9%) |
| Dec 2002 | $8.92M(+242.8%) | $1.76M(-11.5%) | $8.92M(+19.1%) |
| Sep 2002 | - | $1.99M(-45.7%) | $7.49M(+18.6%) |
| Jun 2002 | - | $3.66M(+139.7%) | $6.31M(+85.1%) |
| Mar 2002 | - | $1.52M(+370.7%) | $3.41M(+31.0%) |
| Dec 2001 | $2.60M(-37.1%) | $324.00K(-60.0%) | $2.60M(-26.9%) |
| Sep 2001 | - | $809.00K(+7.4%) | $3.56M(-9.0%) |
| Jun 2001 | - | $753.00K(+5.0%) | $3.91M(-1.6%) |
| Mar 2001 | - | $717.00K(-44.2%) | $3.98M(-4.0%) |
| Dec 2000 | $4.14M(-8.9%) | $1.28M(+10.7%) | $4.14M(+6.1%) |
| Sep 2000 | - | $1.16M(+42.3%) | $3.90M(+3.2%) |
| Jun 2000 | - | $815.00K(-7.6%) | $3.78M(-7.0%) |
| Mar 2000 | - | $882.00K(-15.8%) | $4.07M(-11.3%) |
| Dec 1999 | $4.55M(-44.2%) | $1.05M(+0.9%) | $4.58M(-2.2%) |
| Sep 1999 | - | $1.04M(-5.6%) | $4.69M(-18.5%) |
| Jun 1999 | - | $1.10M(-21.4%) | $5.75M(-22.8%) |
| Mar 1999 | - | $1.40M(+22.0%) | $7.45M(-8.6%) |
| Dec 1998 | $8.15M(+98.7%) | $1.15M(-45.3%) | $8.15M(+0.6%) |
| Sep 1998 | - | $2.10M(-25.0%) | $8.10M(+15.7%) |
| Jun 1998 | - | $2.80M(+33.3%) | $7.00M(+32.1%) |
| Mar 1998 | - | $2.10M(+90.9%) | $5.30M(+32.5%) |
| Dec 1997 | $4.10M(+115.8%) | $1.10M(+10.0%) | $4.00M(+37.9%) |
| Sep 1997 | - | $1.00M(-9.1%) | $2.90M(-3.3%) |
| Jun 1997 | - | $1.10M(+37.5%) | $3.00M(-9.1%) |
| Mar 1997 | - | $800.00K(-27.3%) | $3.30M(-21.4%) |
| Dec 1996 | $1.90M(-51.3%) | - | - |
| Sep 1996 | - | $1.10M(-21.4%) | $4.20M(+7.7%) |
| Jun 1996 | $3.90M(+34.5%) | $1.40M(+40.0%) | $3.90M(+11.4%) |
| Mar 1996 | - | $1.00M(+42.9%) | $3.50M(+9.4%) |
| Dec 1995 | - | $700.00K(-12.5%) | $3.20M(+3.2%) |
| Sep 1995 | - | $800.00K(-20.0%) | $3.10M(+3.3%) |
| Jun 1995 | $2.90M(+38.1%) | $1.00M(+42.9%) | $3.00M(+11.1%) |
| Mar 1995 | - | $700.00K(+16.7%) | $2.70M(+8.0%) |
| Dec 1994 | - | $600.00K(-14.3%) | $2.50M(+8.7%) |
| Sep 1994 | - | $700.00K(0.0%) | $2.30M(+9.5%) |
| Jun 1994 | $2.10M | $700.00K(+40.0%) | $2.10M(+50.0%) |
| Mar 1994 | - | $500.00K(+25.0%) | $1.40M(+55.6%) |
| Dec 1993 | - | $400.00K(-20.0%) | $900.00K(+80.0%) |
| Sep 1993 | - | $500.00K | $500.00K |
FAQ
- What is Moderna, Inc. annual revenue?
- What is the all time high annual revenue for Moderna, Inc.?
- What is Moderna, Inc. annual revenue year-on-year change?
- What is Moderna, Inc. quarterly revenue?
- What is the all time high quarterly revenue for Moderna, Inc.?
- What is Moderna, Inc. quarterly revenue year-on-year change?
- What is Moderna, Inc. TTM revenue?
- What is the all time high TTM revenue for Moderna, Inc.?
- What is Moderna, Inc. TTM revenue year-on-year change?
What is Moderna, Inc. annual revenue?
The current annual revenue of MRNA is $3.24B
What is the all time high annual revenue for Moderna, Inc.?
Moderna, Inc. all-time high annual revenue is $19.11B
What is Moderna, Inc. annual revenue year-on-year change?
Over the past year, MRNA annual revenue has changed by -$3.60B (-52.69%)
What is Moderna, Inc. quarterly revenue?
The current quarterly revenue of MRNA is $142.00M
What is the all time high quarterly revenue for Moderna, Inc.?
Moderna, Inc. all-time high quarterly revenue is $7.14B
What is Moderna, Inc. quarterly revenue year-on-year change?
Over the past year, MRNA quarterly revenue has changed by -$99.00M (-41.08%)
What is Moderna, Inc. TTM revenue?
The current TTM revenue of MRNA is $3.08B
What is the all time high TTM revenue for Moderna, Inc.?
Moderna, Inc. all-time high TTM revenue is $22.88B
What is Moderna, Inc. TTM revenue year-on-year change?
Over the past year, MRNA TTM revenue has changed by -$1.96B (-38.95%)